PROEHL GERALD T — SEC Form 4 filings
SEC reporting owner CIK 1279191. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-08-08 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,666 shares.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | Director | 4 | 1 leg · 1,666 sh | — | 5 |
| Dermata Therapeutics, Inc. (DRMA) | PRESIDENT, CHAIRMAN, CEO, Director, 10% owner | 5 | — | — | 18 |
Form 4 filings — PROEHL GERALD T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Dermata Therapeutics, Inc. (DRMA) | Grant/award (A): 170,068 · Grant/award (A): 1,360,544 (derivative) · Grant/award (A): 1,360,544 (derivative) · Grant/award (A): 170,068 (derivative) · Grant/award (A): 170,068 (derivative) · Grant/award (A): 1,360,544 (derivative) | EDGAR |
| 2026-01-13 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Dermata Therapeutics, Inc. (DRMA) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Dermata Therapeutics, Inc. (DRMA) | Grant/award (A): 490,196 · Grant/award (A): 122,549 · Grant/award (A): 490,196 (derivative) · Grant/award (A): 490,196 (derivative) · Grant/award (A): 122,549 (derivative) · Grant/award (A): 122,549 (derivative) · +2 more | EDGAR |
| 2025-07-03 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Dermata Therapeutics, Inc. (DRMA) | Grant/award (A): 787,402 · Grant/award (A): 787,402 (derivative) | EDGAR |
| 2025-01-14 | 4 | Dermata Therapeutics, Inc. (DRMA) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | TENAX THERAPEUTICS, INC. (TENX) | Purchase (P): 1,666 · Purchase (P): 31,654 (derivative) · Purchase (P): 16,660 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1279191 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →